Market access support for Constella
Constella was the first product with approved indication to treat IBS-C. Our support included development of reimbursement dossiers and health economic model development
Do you need assistance with applying for reimbursement in any of the Nordic countries?
Obtaining general reimbursement is key to ensure market access for new prescription drugs. We have extensive experience with the development of reimbursement applications in the Nordic countries
Services
We can assist you in all parts of the process, and we tailor our service to your needs. Reimbursement application can involve:
- development of situation analysis
- input to strategy
- facilitating meetings with authorities
- collection of local data
- securing clinical expert input
- development of dossier
- adaptation of economic models
- submission
- answering of questions from authorities
- negotiations
We ensure that the reimbursement applications and health economic models fulfil the country specific requirements.
Approach
Experience Application for reimbursement is a core competence for us, and we have 10+ years of experience with the processes in the Nordic countries.
Your goal is our goal Our focus is to meet your objectives and to deliver the service that meets your needs. We partner with you to meet the defined objectives. We are dedicated and strive to obtain reimbursement in the Nordic markets for your product
Time is critical We know that time to reimbursement matters, and it is crucial for us to deliver to agreed timelines.